Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Heather A Hirsch

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Molecular Cell|September 14, 2010
Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cellsDimitrios Iliopoulos, Marianne Lindahl-Allen, Christos Polytarchou, et al.
Cancer Cell|April 14, 2010
A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseasesHeather A Hirsch, Dimitrios Iliopoulos, Amita Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II TrialOliver Dorigo, Amit M Oza, Tanja Pejovic, et al.
Molecular Cancer Therapeutics|May 24, 2013
Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapyAmy D Guertin, Jing Li, Yaping Liu, et al.
Plos One|October 8, 2014
MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosisRobert N Booher, Harold Hatch, Brian M Dolinski, et al.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
Nature|June 16, 2007
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project, Ewan Birney, John A Stamatoyannopoulos, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Molecular Cell|September 14, 2010
Loss of miR-200 inhibition of Suz12 leads to polycomb-mediated repression required for the formation and maintenance of cancer stem cellsDimitrios Iliopoulos, Marianne Lindahl-Allen, Christos Polytarchou, et al.
Cancer Cell|April 14, 2010
A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseasesHeather A Hirsch, Dimitrios Iliopoulos, Amita Joshi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 2023
Maveropepimut-S, a DPX-Based Immune-Educating Therapy, Shows Promising and Durable Clinical Benefit in Patients with Recurrent Ovarian Cancer, a Phase II TrialOliver Dorigo, Amit M Oza, Tanja Pejovic, et al.
Molecular Cancer Therapeutics|May 24, 2013
Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapyAmy D Guertin, Jing Li, Yaping Liu, et al.
Plos One|October 8, 2014
MCL1 and BCL-xL levels in solid tumors are predictive of dinaciclib-induced apoptosisRobert N Booher, Harold Hatch, Brian M Dolinski, et al.
Molecular Cancer Therapeutics|December 30, 2021
Reverse Translating Molecular Determinants of Anti-Programmed Death 1 Immunotherapy Response in Mouse Syngeneic Tumor ModelsPeter Georgiev, Eric S Muise, Douglas E Linn, et al.
Nature|June 16, 2007
Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project, Ewan Birney, John A Stamatoyannopoulos, et al.
Pageof 2